We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

127 hedge funds and large institutions have $784M invested in Foundation Medicine, Inc. in 2017 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 11

177% more call options, than puts

Call options by funds: $40.6M | Put options by funds: $14.7M

65% more capital invested

Capital invested by funds: $476M → $784M (+$307M)

31% more funds holding

Funds holding: 97127 (+30)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 33

Holders
127
Holders Change
+30
Holders Change %
+30.93%
% of All Funds
2.88%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
42
Increased
30
Reduced
33
Closed
11
Calls
$40.6M
Puts
$14.7M
Net Calls
+$25.9M
Net Calls Change
+$10.3M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
1
Gilder Gagnon Howe & Co
New York
$103M -$932K -17,963 -1%
BlackRock
2
BlackRock
New York
$96.4M -$1.49M -28,731 -2%
Chevy Chase Trust
3
Chevy Chase Trust
Maryland
$72.8M +$475K +9,152 +0.9%
OC
4
Oppenheimer & Co
New York
$48.6M -$546K -10,520 -1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$45M +$516K +9,953 +2%
Lord, Abbett & Co
6
Lord, Abbett & Co
New Jersey
$40.6M -$2.32M -44,668 -7%
CC
7
Casdin Capital
New York
$35.5M +$2.07M +40,000 +8%
State Street
8
State Street
Massachusetts
$30.7M -$6.58M -126,965 -22%
HCM
9
Hitchwood Capital Management
New York
$24.6M +$18.7M +360,000 New
Baillie Gifford & Co
10
Baillie Gifford & Co
United Kingdom
$20.9M +$2.66M +51,368 +20%
AllianceBernstein
11
AllianceBernstein
Tennessee
$20.8M -$19.1M -368,544 -55%
PCM
12
Peregrine Capital Management
Minnesota
$19.2M -$2.54M -48,957 -15%
AAMU
13
Amundi Asset Management US
Massachusetts
$18.7M -$2.81M -54,107 -16%
AIM
14
ARK Investment Management
Florida
$17.6M -$2.76M -53,183 -17%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$17.5M +$13.3M +255,939 New
BA
16
Boston Advisors
Massachusetts
$13M +$9.88M +190,620 New
Northern Trust
17
Northern Trust
Illinois
$12.7M -$167K -3,222 -2%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$11M +$948K +18,289 +13%
ACM
19
Adalta Capital Management
New York
$8.84M -$25.9K -500 -0.4%
CLCM
20
Crawford Lake Capital Management
New Jersey
$7.44M +$5.66M +109,116 New
Macquarie Group
21
Macquarie Group
Australia
$7.01M -$197K -3,795 -4%
BAMCO Inc
22
BAMCO Inc
New York
$6.05M -$114K -2,200 -2%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$5.24M -$236K -4,560 -6%
AR
24
Advisory Research
Illinois
$5.22M +$2.51M +48,450 +172%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$5.09M +$3.87M +74,612 New

FMI Hedge Fund Activity: Q4 2017 in Review

127 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2017, worth a combined $784M — up 65% from $476M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FMI positions and 11 closed out — a net gain of 31 holders — while 30 added to existing stakes and 33 trimmed.

The largest buyer was Hitchwood Capital Management, opening a new position worth an estimated $18.7M. The largest seller was AllianceBernstein, cutting an estimated $19.1M.

  • 127 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2017, up from 97 in Q3 2017.
  • Funds reported $784M of Foundation Medicine, Inc. stock for Q4 2017, up 65% quarter-over-quarter.
  • 42 funds opened new Foundation Medicine, Inc. positions in Q4 2017 and 11 closed out, a net change of +31 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2017 was Hitchwood Capital Management, an estimated $18.7M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2017 was AllianceBernstein, an estimated $19.1M sold.

Based on aggregated 13F filings for Q4 2017.